Greg Kidd to Lead Know Labs with Bitcoin-Centric Treasury Strategy and Acquire Controlling Stake
Know Labs, Inc. (NYSE American: KNW) (“Know Labs” or the “Company”), a pioneering innovator in non-invasive health monitoring solutions, has announced a transformative agreement with Goldeneye 1995 LLC (“Buyer”), an entity affiliated with renowned fintech investor, entrepreneur, and former Ripple Chief Risk Officer Greg Kidd. Under the terms of the deal, Mr. Kidd will acquire a controlling interest in Know Labs and assume the roles of Chief Executive Officer and Chairman of the Board of Directors upon the transaction’s closing.
The acquisition marks a bold strategic pivot for Know Labs, as it integrates a Bitcoin treasury strategy into its operations. This move positions the company at the intersection of cutting-edge health technology and the rapidly growing digital asset ecosystem, creating a unique value proposition for investors and stakeholders alike.
Strategic Acquisition and Bitcoin Treasury Initiative
Under the agreement, the Buyer will acquire a significant number of shares of Know Labs’ common stock. The purchase price will be determined by dividing (i) the sum of 1,000 Bitcoin and a cash amount allocated to retire existing debt, redeem outstanding preferred equity, and provide additional working capital, by (ii) the per-share purchase price of $0.335. This structure ensures that Bitcoin becomes a cornerstone of the Company’s treasury strategy, offering shareholders substantial economic exposure to one of the most sought-after digital assets in today’s market.
Greg Kidd expressed his enthusiasm for the partnership, stating, “I’m thrilled to deploy a Bitcoin treasury strategy with the support of a forward-looking organization like Know Labs, especially during a time when market and regulatory conditions are particularly favorable. We believe this approach will generate sustainable growth and long-term shareholder value.” Mr. Kidd, who brings extensive expertise in digital assets and blockchain technologies, plans to transition his existing Bitcoin yield generation strategy to the public markets through this acquisition.
By making Bitcoin the principal component of its balance sheet, Know Labs will adopt the multiple of net asset value (“mNAV”) metric to evaluate how the market values the company relative to its Bitcoin holdings. Assuming a Bitcoin price of $105,000 per coin at closing, the Company’s implied entry mNAV multiple is 1.22x, with Bitcoin representing approximately 82% of its $128 million market capitalization. This innovative framework underscores the Company’s commitment to transparency and aligning shareholder interests with the performance of its digital asset portfolio.
A New Chapter for Know Labs
While the acquisition ushers in a new era for Know Labs, the Company remains deeply committed to advancing its core mission of developing non-invasive health monitoring technologies. Founder Ron Erickson will continue to play a pivotal role in the organization, serving as President of a newly formed division dedicated to proprietary diagnostic research. This division will retain a team of scientists focused on pushing the boundaries of medical innovation.
Upon the transaction’s closing, Mr. Erickson will also assume the position of Vice Chairman of the Board. Reflecting on the partnership, he remarked, “Partnering with Greg Kidd marks a pivotal next chapter for Know Labs. We look forward to continuing our research in non-invasive medical technology while benefiting from Greg’s visionary leadership. His expertise in digital assets and fintech positions Know Labs for a bold and exciting future.”
Unanimous Approval and Expected Timeline
The transaction has been unanimously approved by Know Labs’ Board of Directors, underscoring their confidence in the strategic direction set forth by Mr. Kidd. The deal is expected to close in the third quarter of 2025, contingent upon receiving shareholder approval and satisfying customary closing conditions. Once completed, the acquisition will solidify Know Labs’ position as a leader in both health technology and digital asset innovation.
Bridging Health Tech and Digital Assets
This landmark agreement highlights the convergence of two transformative industries—healthcare and digital assets. By integrating a Bitcoin-centric treasury strategy, Know Labs not only diversifies its financial resources but also taps into the growing demand for exposure to decentralized digital currencies. At the same time, the Company continues to advance its groundbreaking work in non-invasive diagnostics, ensuring that its legacy of innovation remains intact.
Greg Kidd’s leadership and vision promise to unlock new opportunities for Know Labs, balancing the adoption of cutting-edge blockchain technologies with the Company’s longstanding commitment to improving healthcare outcomes. As the transaction progresses toward completion, all eyes will be on Know Labs as it embarks on this ambitious journey to redefine its identity and chart a course for sustained success.
For more information about the transaction and its implications, shareholders and interested parties are encouraged to review the official filings and disclosures provided by Know Labs. With its sights set on the future, the Company is poised to emerge as a trailblazer in both the health tech and digital asset sectors, delivering value to investors and society alike.
About Greg Kidd
Greg Kidd is co-founder and CEO of Hard Yaka, a venture capital firm, and the majority shareholder of OCC-chartered Vast Bank. As an investor, Greg provided first money at Twitter, Square (Block), Coinbase, Robinhood, and Solana. Other early investments include Ripple, Uphold, and Brave. After working at consulting firm Booz Allen Hamilton, he took his first company public on the NASDAQ in the 1990s. He later served in the payments division of the Federal Reserve and as a director at Promontory Financial Group. Greg also served as Chief Risk Officer at Ripple. Greg graduated from Brown University and earned an MBA from Yale University and an MPA in public policy from Harvard’s Kennedy School. Greg Kidd was a nonpartisan 2024 candidate for Congress in Nevada’s 2nd District.
About Know Labs, Inc.
Know Labs, Inc. is a public company whose common shares trade on the NYSE American Exchange under the stock symbol “KNW.” The Company’s platform technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a unique molecular signature. The technology can be integrated into a variety of wearable, mobile or bench-top form factors. This patented and patent-pending technology makes it possible to effectively identify and monitor analytes that could only previously be performed by invasive and/or expensive and time-consuming lab-based tests. The first application of the technology will be in a product marketed as a non-invasive glucose monitor. The device will provide the user with accessible and affordable real-time information on blood glucose levels. This product will require U.S. Food and Drug Administration clearance prior to its introduction to the market. Other products, based upon the Company’s technology may not require such FDA approval.
